Skip to main content
Passa alla visualizzazione normale.


Pari opportunità

SILVIO BUSCEMI

Ultra-long-acting insulin degludec has consistently lower pharmacodynamic variability than insulin glargine over 24 h at steady state

  • Authors: Buscemi, S; Heise, T; Hermanski, L; Nosek, L; Feldmann, A; Rasmussen, S; Nicoziani, P; Haahr, S
  • Publication year: 2012
  • Type: Abstract in rivista (Abstract in rivista)
  • Key words: diabetes, insulin degludec, pharmacodynamic variability
  • OA Link: http://hdl.handle.net/10447/79630